• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迁移性和驻留性树突状细胞在黏膜或皮肤单纯疱疹病毒1型感染后T细胞启动中的不同作用。

Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection.

作者信息

Lee Heung Kyu, Zamora Melodie, Linehan Melissa M, Iijima Norifumi, Gonzalez David, Haberman Ann, Iwasaki Akiko

机构信息

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.

出版信息

J Exp Med. 2009 Feb 16;206(2):359-70. doi: 10.1084/jem.20080601. Epub 2009 Jan 19.

DOI:10.1084/jem.20080601
PMID:19153243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2646574/
Abstract

Although mucosal surfaces represent the main portal of entry for pathogens, the mechanism of antigen presentation by dendritic cells (DCs) that patrol various mucosal tissues remains unclear. Instead, much effort has focused on the understanding of initiation of immune responses generated against antigens delivered by injection. We examined the contributions of migratory versus lymph node-resident DC populations in antigen presentation to CD4 and CD8 T cells after needle injection, epicutaneous infection, or vaginal mucosal herpes simplex virus (HSV) 1 infection. We show that upon needle injection, HSV-1 became lymph-borne and was rapidly presented by lymph node-resident DCs to CD4 and CD8 T cells. In contrast, after vaginal HSV-1 infection, antigens were largely presented by tissue-derived migrant DCs with delayed kinetics. In addition, migrant DCs made more frequent contact with HSV-specific T cells after vaginal infection compared with epicutaneous infection. Thus, both migrant and resident DCs play an important role in priming CD8 and CD4 T cell responses, and their relative importance depends on the mode of infection in vivo.

摘要

尽管黏膜表面是病原体进入的主要门户,但巡逻于各种黏膜组织的树突状细胞(DC)进行抗原呈递的机制仍不清楚。相反,很多研究致力于理解针对注射递送抗原所产生的免疫反应的起始过程。我们研究了在针刺注射、皮肤感染或阴道黏膜单纯疱疹病毒1(HSV-1)感染后,迁移性DC群体与淋巴结驻留DC群体在向CD4和CD8 T细胞呈递抗原方面的作用。我们发现,针刺注射后,HSV-1通过淋巴传播,并迅速由淋巴结驻留DC呈递给CD4和CD8 T细胞。相比之下,阴道HSV-1感染后,抗原主要由组织来源的迁移性DC呈递,动力学延迟。此外,与皮肤感染相比,阴道感染后迁移性DC与HSV特异性T细胞的接触更频繁。因此,迁移性DC和驻留DC在启动CD8和CD4 T细胞反应中都发挥着重要作用,它们的相对重要性取决于体内的感染方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/eb8548692c53/JEM_20080601_RGB_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/8cba8803fd77/JEM_20080601R_LW_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/a4a2edfed545/JEM_20080601_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/53c615763169/JEM_20080601_LW_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/fba051e11149/JEM_20080601_RGB_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/f282119dfa51/JEM_20080601_GS_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/eb8548692c53/JEM_20080601_RGB_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/8cba8803fd77/JEM_20080601R_LW_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/a4a2edfed545/JEM_20080601_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/53c615763169/JEM_20080601_LW_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/fba051e11149/JEM_20080601_RGB_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/f282119dfa51/JEM_20080601_GS_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb8/2646574/eb8548692c53/JEM_20080601_RGB_Fig6.jpg

相似文献

1
Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection.迁移性和驻留性树突状细胞在黏膜或皮肤单纯疱疹病毒1型感染后T细胞启动中的不同作用。
J Exp Med. 2009 Feb 16;206(2):359-70. doi: 10.1084/jem.20080601. Epub 2009 Jan 19.
2
Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.阴道黏膜下树突状细胞而非朗格汉斯细胞可诱导针对单纯疱疹病毒2型的保护性Th1反应。
J Exp Med. 2003 Jan 20;197(2):153-62. doi: 10.1084/jem.20021109.
3
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells.皮肤来源的CD103⁺树突状细胞对病毒和自身抗原的交叉呈递。
Nat Immunol. 2009 May;10(5):488-95. doi: 10.1038/ni.1724. Epub 2009 Apr 6.
4
Effective Priming of Herpes Simplex Virus-Specific CD8 T Cells Does Not Require Infected Dendritic Cells.单纯疱疹病毒特异性CD8 T细胞的有效启动不需要受感染的树突状细胞。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01508-17. Print 2018 Feb 1.
5
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.迁移性树突状细胞将抗原传递给淋巴结驻留树突状细胞群体,以有效地启动细胞毒性T淋巴细胞。
Immunity. 2006 Jul;25(1):153-62. doi: 10.1016/j.immuni.2006.04.017.
6
In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.体内清除CD11c阳性树突状细胞会增加对1型单纯疱疹病毒感染的易感性,并削弱自然杀伤细胞和T细胞反应。
J Virol. 2006 Apr;80(8):3985-93. doi: 10.1128/JVI.80.8.3985-3993.2006.
7
Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection.树突状细胞亚群的时空特异性相互作用有助于局部病毒感染中 CD4+和 CD8+T 细胞的激活。
Immunity. 2015 Sep 15;43(3):554-65. doi: 10.1016/j.immuni.2015.07.020. Epub 2015 Aug 18.
8
Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8 T and T Cell Responses against Herpesvirus Infection and Disease.激光辅助肽疫苗促进树突状细胞向皮肤迁移,并增强针对疱疹病毒感染和疾病的保护性CD8 T细胞和T细胞反应。
J Virol. 2018 Mar 28;92(8). doi: 10.1128/JVI.02156-17. Print 2018 Apr 15.
9
Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.单纯疱疹病毒 1 特异性靶向人类 CD1d 抗原呈递以增强其致病性。
J Virol. 2018 Oct 29;92(22). doi: 10.1128/JVI.01490-18. Print 2018 Nov 15.
10
Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.皮肤 RANK-RANKL 信号通过阻止病毒诱导的朗格汉斯细胞凋亡,上调单纯疱疹病毒感染期间 CD8+介导的抗病毒免疫。
J Invest Dermatol. 2015 Nov;135(11):2676-2687. doi: 10.1038/jid.2015.225. Epub 2015 Jun 15.

引用本文的文献

1
The Epithelial Immune Response to Human Papillomavirus Infection.上皮细胞对人乳头瘤病毒感染的免疫反应
Pathogens. 2025 May 9;14(5):464. doi: 10.3390/pathogens14050464.
2
Viral Infection and Dissemination Through the Lymphatic System.病毒感染与通过淋巴系统的传播
Microorganisms. 2025 Feb 18;13(2):443. doi: 10.3390/microorganisms13020443.
3
Alkaline Adjuvant Regulates Proteolytic Activity of Macrophages for Antigen Cross-Presentation and Potentiates Radioimmunotherapy.碱性佐剂调节巨噬细胞的蛋白水解活性以进行抗原交叉呈递并增强放射免疫疗法。

本文引用的文献

1
Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells.迁移性树突状细胞和驻留在淋巴组织中的树突状细胞协同作用,高效启动初始CD4 T细胞。
Immunity. 2008 Nov 14;29(5):795-806. doi: 10.1016/j.immuni.2008.08.013. Epub 2008 Oct 23.
2
Multiple dendritic cell populations activate CD4+ T cells after viral stimulation.病毒刺激后,多种树突状细胞群体激活CD4+ T细胞。
PLoS One. 2008 Feb 27;3(2):e1691. doi: 10.1371/journal.pone.0001691.
3
Vaginal epithelial dendritic cells renew from bone marrow precursors.
Adv Mater. 2025 Mar;37(12):e2416690. doi: 10.1002/adma.202416690. Epub 2025 Feb 11.
4
Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes.通过基因递送展示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的包膜病毒样颗粒增强抗SARS-CoV-2中和免疫
Vaccines (Basel). 2023 Aug 31;11(9):1438. doi: 10.3390/vaccines11091438.
5
Life and death of tolerogenic dendritic cells.耐受性树突状细胞的生与死。
Trends Immunol. 2023 Feb;44(2):110-118. doi: 10.1016/j.it.2022.12.006. Epub 2023 Jan 2.
6
Antigen transfer and its effect on vaccine-induced immune amplification and tolerance.抗原转移及其对疫苗诱导免疫放大和耐受的影响。
Theranostics. 2022 Aug 1;12(13):5888-5913. doi: 10.7150/thno.75904. eCollection 2022.
7
Characterization of the Immunologic Phenotype of Dendritic Cells Infected With Herpes Simplex Virus 1.单纯疱疹病毒 1 感染的树突状细胞免疫表型特征。
Front Immunol. 2022 Jul 5;13:931740. doi: 10.3389/fimmu.2022.931740. eCollection 2022.
8
HSV-1 Infection of Epithelial Dendritic Cells Is a Critical Strategy for Interfering with Antiviral Immunity.单纯疱疹病毒 1 感染上皮树突状细胞是干扰抗病毒免疫的关键策略。
Viruses. 2022 May 14;14(5):1046. doi: 10.3390/v14051046.
9
Hapten sensitization to vaginal mucosa induces less recruitment of dendritic cells accompanying TGF-β-expressing CD206 cells compared with skin.与皮肤相比,经阴道黏膜递呈半抗原致敏会导致树突状细胞募集减少,同时伴有 TGF-β 表达的 CD206 细胞。
Immun Inflamm Dis. 2022 Apr;10(4):e605. doi: 10.1002/iid3.605.
10
Plasmacytoid Dendritic Cells and Cancer Immunotherapy.浆细胞样树突状细胞与癌症免疫治疗。
Cells. 2022 Jan 11;11(2):222. doi: 10.3390/cells11020222.
阴道上皮树突状细胞由骨髓前体细胞更新而来。
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19061-6. doi: 10.1073/pnas.0707179104. Epub 2007 Nov 15.
4
Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells.皮肤来源的树突状细胞可介导I类限制性自身反应性T细胞的删除性耐受。
J Immunol. 2007 Oct 1;179(7):4535-41. doi: 10.4049/jimmunol.179.7.4535.
5
Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells.浆细胞样树突状细胞对初始CD4⁺而非CD8⁺T细胞进行器官依赖性体内启动。
J Exp Med. 2007 Aug 6;204(8):1923-33. doi: 10.1084/jem.20062373. Epub 2007 Jul 23.
6
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.树突状细胞亚群在体内的固有和协同抗原呈递功能。
Nat Rev Immunol. 2007 Jul;7(7):543-55. doi: 10.1038/nri2103.
7
Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania.在感染部位形成的单核细胞衍生树突状细胞控制针对利什曼原虫的保护性辅助性T细胞1型反应的诱导。
Immunity. 2007 Apr;26(4):519-31. doi: 10.1016/j.immuni.2007.01.017. Epub 2007 Apr 5.
8
Mucosal dendritic cells.黏膜树突状细胞
Annu Rev Immunol. 2007;25:381-418. doi: 10.1146/annurev.immunol.25.022106.141634.
9
Differential antigen processing by dendritic cell subsets in vivo.体内树突状细胞亚群的差异抗原处理
Science. 2007 Jan 5;315(5808):107-11. doi: 10.1126/science.1136080.
10
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.迁移性树突状细胞将抗原传递给淋巴结驻留树突状细胞群体,以有效地启动细胞毒性T淋巴细胞。
Immunity. 2006 Jul;25(1):153-62. doi: 10.1016/j.immuni.2006.04.017.